Slides and Webcasts from all ESMO Advanced Courses are reserved to ESMO Members and registered participants, according to the presenters' agreement to release them. ESMO thanks the authors for their generosity.
ESMO Advanced Course on EGFR in Lung Cancer 2024: Hong Kong SAR, China
- Start date
- 26 Jan 2024
- End date
- 27 Jan 2024
- Location
- Hong Kong SAR, China
Learning objectives
- To understand the role of molecular diagnostic test on tissue and plasma samples for diagnosis, monitoring and TKI resistance in management of EGFR M+ lung cancer
- To comprehend management of early stage and local advanced EGFR M+ lung cancer
- To gain updated information on optimal first line management and treatment of TKI resistance
- To interrogate the potential use of immunotherapy for patients with EGFR M+ lung cancer
Accreditation
The programme of this event has been accredited with 9 ESMO-MORA category 1 points. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. Recertification guarantees that a certified medical oncologist has continued to update her/his knowledge and continues to possess the necessary skills and standards for the practice of medical oncology. For further details, please refer to ESMO-MORA Recertification Process & Requirements.
Co-Chairs
- Tony S. K. Mok, Hong Kong SAR, China
- Solange Peters, Switzerland
Supported by
